AOR L-Lysine 500 mg - 150 Capsules
AOR L-Lysine, providing a clinically effective dose, helps fight cold sores and boosts immunity, while supporting muscle and bone health.
Brand: Advanced Orthomolecular Research (AOR)
Format: Capsules
Amount: 150 Capsules
General Product Information:
Reduces the severity and healing time of cold sores.
An essential amino acid.
Helps reduce the recurrence, severity, and healing time of cold sores.
L-Lysine is an essential amino acid that is important for many biological functions such as immunity, energy production, and muscle growth. Since it is naturally abundant in high protein foods such as meat, eggs, beans, and legumes, those likely to suffer from deficiency are vegetarians or vegans who consume a diet low in legumes and high in grain based foods.
One of the most common uses for supplemental L-lysine is for preventing cold sores caused by the Herpes simplex virus. It does this in three different ways: by preventing infection with the virus, reducing the risk of developing cold sores in those with the virus and speeding up recovery after cold sores develop. Lysine inhibits replication of the herpes virus that causes the visible outbreaks and pain, itching, and sores around the lips. It interferes with absorption of the amino acid arginine, which the herpes virus uses to replicate. Without arginine, the virus can not be fully functional which allows the body to heal quicker and reduce the possibility of recurrence.
AOR's L-lysine offers a safe and effective dose of high quality pure L-lysine.
Medicinal Ingredients - Each Capsule Contains:
L-Lysine* ..... 500 mg
*Production from biofermentation.
Non-Medicinal Ingredients*: Microcrystalline cellulose and sodium stearyl fumarate.
*NMI's are subject to change. Always read and follow the label for accurate ingredient and allergen information.
Dosage:
Adult: take two capsules three times daily for up to six months or as directed by a qualified health care practitioner.
NPN: 80002854
Product Information on this Page was Last Updated on: February 27, 2026.